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Abstract
Cyathostomins are ubiquitous parasitic nematodes of horses. These worms spend 
substantial periods as intestinal wall stage encysted larvae, which can comprise up to 90% 
of the total burden. Several million larvae have been reported in individuals. Emergence of 
these larvae from the gut wall can lead to life-threatening colitis. Faecal egg count tests, 
increasingly used by horse owners to inform anthelmintic treatments, do not correlate with 
the intra-host burden of cyathostomins; this represents an key gap in the diagnostic 
toolbox. Previously, a cyathostomin Gut Associated Larval Antigen (Cy-GALA) was 
identified as a promising marker for the intra-host stages of infection. Here, Cy-GALA and 
an additional protein, Cyathostomin Immuno-diagnostic (Cy-CID) antigen, were 
investigated to examine their value in providing information on cyathostomin burden. 
ELISA analyses examined serum IgG(T) responses to recombinant proteins derived from 
individual cyathostomin species. Receiver Operator Characteristic (ROC) curve analysis 
was performed on the ELISA data; proteins with the highest Area Under the Curve (AUC) 
values were selected to test protein combinations to investigate which were the most 
informative in identifying the infection status of individuals. Three cocktail (CT) 
combinations were tested, comprising: a) Cy-GALA proteins from two species and a Cy-
CID protein from a third species (CT3), b) Cy-GALA proteins from five species (CT5), 
and c) all CT5 components, plus a Cy-CID protein from an additional species (CT6).  The 
best predictive values for infection were obtained using CT3 and CT6, with similar values 
achieved for both. Proteins in CT3 are derived from the most commonly reported species, 
Cyathostomum catinatum, Cylicocyclus nassatus and Cylicostephanus longibursatus. This 
combination was selected for future development since it represents a more commercially 
viable format for a diagnostic test.  
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New nucleotide sequences reported in this manuscript have been submitted to GenBank
under accession numbers KC759138 (Cy-CID-ash), KC759134 (Cy-CID-gol), KC759133 
(Cy-CID-lon), KC759139 (Cy-CID-nas), KC759131 (Cy-CID-pat). 
1. Introduction 
 
Cyathostomins are highly prevalent pathogenic equine nematodes (Matthews, 2008). 
Approximately 50 individual species are classified in this group (Lichtenfels et al., 2008); 
however, in individuals, the majority of the burden comprises 5-10 common species with 
other species having a low abundance (Mfitilodze and Hutchinson, 1990; Bucknell et al., 
1995; Lyons et al., 1999; Chapman et al., 2002a; Collobert-Laugier et al., 2002). Across 
regions, similar species proportions are found. Globally, the commonest species are 
Cyathostomum catinatum, Cylicostephanus longibursatus and Cylicocyclus nassatus 
(Ogbourne, 1976; Reinemeyer et al., 1984; Krecek et al., 1989; Mfitilodze and 
Hutchinson, 1990; Bucknell et al., 1995; Gawor, 1995; Lichtenfels et al., 2001; Collobert-
Laugier et al., 2002). Cyathostomins spend a sizeable part of their life cycle as encysted 
larvae in the mucosa/sub-mucosa of the caecum and colon. Experimental studies 
demonstrate that these larvae can persist for many months (Murphy and Love, 1997). In 
natural infections, encysted larvae have been found to comprise over 90% of the total 
burden (Collobert-Laugier et al., 2002; Dowdall et al., 2002), with counts in excess of 5 
million larvae recorded (Dowdall et al., 2002). Mass emergence of larvae from the 
intestinal wall causes larval cyathostominosis leading to sudden onset colitis, which has a 
case fatality rate of up to 50% (Giles et al., 1985; Love et al., 1992).   
Effective cyathostomin control is complicated by a high prevalence of anthelmintic 
resistance to benzimidazole and pyrantel compounds (Kaplan, 2002; Matthews, 2014). 
There are also reports of emerging resistance to the commonly used macrocyclic lactones, 
measured as a reduced strongyle egg reappearance period after treatment (Rossano et al., 
2010; Canever et al., 2013; Geurden et al., 2014; Relf et al., 2014; Tzelos et al., 2017). As 
no new anthelmintic classes are under development for use in horses in the short to 
medium term, it is important that the efficacy of currently effective compounds is
preserved. Recommendations for control now place a strong emphasis on reducing 
anthelmintic treatment frequency (Matthews, 2014; Tzelos and Matthews, 2016). Because 
cyathostomin infections exhibit a negative binomial distribution amongst hosts (Lester et 
al., 2013; Relf et al., 2013; Wood et al., 2013), substantial reductions in treatment levels 
can be achieved by targeting anthelmintics based on worm egg shedding levels. Faecal 
egg count (FEC)-directed treatments are thus recommended (Sangster, 2003; Kaplan and 
Nielsen, 2010; Nielsen et al., 2014; Tzelos and Matthews, 2016), with good uptake in 
some regions (Easton et al., 2016, Tzelos et al., 2019). A main disadvantage of FEC 
analysis is the lack of information on total intra-host burden; in terms of targeting larvae 
to avoid disease, FEC tests therefore do not provide the relevant information. Horses with 
sizeable larval burdens often have no or low worm egg shedding (Dowdall et al., 2002).  
Previously, two native antigen complexes, demonstrated to be targets of serum IgG(T), 
were identified as promising markers of cyathostomin infection (Dowdall et al., 2002; 
Dowdall et al., 2003; Dowdall et al., 2004). As antigen production requires large 
quantities of material from infected horses and purification is technically challenging, 
steps were taken to identify genes that encode protein components of these complexes to 
develop a recombinant protein-based test. Cyathostomin Gut Associated Larval Antigen-1 
(Cy-GALA-1) was identified by immuno-screening a complementary (c)DNA library 
using sera from experimentally infected horses (McWilliam et al., 2010). Cy-GALA-1, 
derived from Cyathostomum pateratum, was shown to be a strong target of serum IgG(T) 
in infected individuals and did not exhibit reactivity to serum from horses infected with 
non-cyathostomin nematodes (McWilliam et al., 2010). Recombinant Cy-GALA proteins 
were generated from four additional species, Cylicocyclus ashworthi (Cy-GALA-ash), 
Cyathostomum catinatum (Cy-GALA-cat), Cylicostephanus goldi (Cy-GALA-gol) and 
Cylicostephanus longibursatus (Cy-GALA-lon) (Mitchell et al., 2016). Antibody 
responses to each protein were assessed to identify if these could detect the presence of 
infection and level of burden and, when used as markers to discriminate infected versus 
un-infected animals, these performed well (Mitchell et al., 2016). Here, because of 
possible genetic restriction of antibody responses against a single recombinant antigen 
(Else and Wakelin, 1989, McKeand et al., 1994), an additional protein, Cyathostomin 
Immuno-Diagnostic (Cy-CID) antigen, was isolated from five common species and serum 
antibody responses assessed in infected and non-infected horses. Serum IgG(T) responses 
to individual Cy-CID and Cy-GALA proteins and three multi-antigen cocktails 
comprising variations of the antigens were then tested for their ability to predict the 
presence of infection and level of burden.  
 
2. MATERIALS AND METHODS 
2.1. Parasite material 
Cyathostomins were obtained from large intestinal luminal contents of naturally 
infected horses and encysted larvae recovered by pepsin-HCl digestion or by manual 
removal from the mucosa and submucosa at post-mortem as described previously 
(Dowdall et al., 2002). Worms were identified to species on morphology based on 
Lichtenfels et al. (2008).  
 
2.2. Serum samples 
For immunoblotting and ELISA studies, sera used here were as described in Mitchell et 
al. (2016), and summarised here in Supplementary Table 1. Samples were included from 
horses maintained under helminth-free conditions (102, 103, 106) and horses (101, 104, 
105) subjected to multiple experimental cyathostomin infections (Murphy and Love, 
1997). Serum collected at Day 0  of the experiment before the infections of 101, 104 and 
105 were considered as negative samples. Details of parasite burdens and species found 
post-mortem in these animals are reported in Murphy and Love (1997). Pools of this sera 
were used as cyathostomin-negative (helminth-free, HF) and -positive control sera 
(cyathostomin infected, CI). The CI pool comprised samples taken 12-16 weeks post-
infection. These time points were selected due to high serum IgG(T) reactivity to native 
larval antigen complexes identified in previous studies (Dowdall et al., 2002). Sera used to 
examine cross-reactivity of each recombinant protein to other species were available from 
horses with mono-specific experimental infections of Strongylus edentatus or Strongylus 
vulgaris (Klei et al., 1982) or with Parascaris spp.  or Strongyloides westeri (Dowdall et 
al., 2003). Sera from additional infected horses from the UK and US were used to further 
investigate immunogenicity of the antigens. For some animals, enumerated nematode 
burden data were available allowing comparison of serum antigen-specific IgG(T) levels 
with cyathostomin burden. 
 
2.3.  Selection of immunogenic antigens for the diagnostic test 
Previously, Cy-GALA-pat protein was selected by immune-screening a cyathostomin 
cDNA library using sera from CI horses (McWilliam et al., 2010). During screening, a 
second protein was identified as strongly reactive to IgG(T) in CI serum. This was 
designated Cyathostomin Immuno-Diagnostic (Cy-CID) antigen as no significant identity 
to other characterised proteins was identified by BLAST searching. Similar to the strategy 
used to ascribe species identity to Cy-gala-pat (Mitchell et al., 2016), nucleotide sequences 
in the Cy-cid library clone were compared with cid sequences obtained by polymerase 
chain reaction (PCR) amplification from individual identified worms of various 
cyathostomin species. On the basis of a comparison of the resultant sequences, the library 
clone sequence was identified as derived from Cylicocyclus nassatus (Cy-CID-nas; 
KC759139.1). Using Cy-cid-nas sequence as template, conserved gene-specific primers 
were designed (Fwd -GGTCACACCACAAGCTCAGGA- -
AGGTGAGCGAACTTT-CTGAA- ) and a region of cy-cid amplified from DNA 
extracted from single identified adult worms of Cyathostomum pateratum, Cylicocyclus 
ashworthi, Cylicostephanus goldi and Cylicostephanus longibursatus employing the 
methodology used for amplifying Cy-gala sequences from single worms (Mitchell et al., 
2016). For size determination, PCR products were analysed on 1.1% w/v agarose TAE 
gels using a TrackIt 100bp DNA Ladder (Invitrogen) and stained with 1 X GelRed 
(Biotium). PCR products were cloned into pGEM®-T Easy, plasmid preparations made 
and inserts sequenced as per Mitchell et al. (2016). To generate PCR products for sub-
cloning for recombinant expression, species-specific primers, incorporating SacI and NotI 
restriction sites (Supplementary Table 2), were designed using cy-cid sequences obtained 
from individual identified worms. Cy-cid sequences were amplified from pGEM®-T and 
sub-cloned into pET-22b(+) (Novagen) as described in McWilliam et al. (2010). Colonies 
were examined by PCR for an insert of the correct estimated size using vector-specific 
primers and plasmid preparations made from two colonies, which were sequenced using 
the same primers. Clones of the correct sequence were transformed into BL21-
CodonPlus(DE3)-RIL cells and expressed (McWilliam et al., 2010). Cy-CID proteins were 
purified from the soluble fraction using HisTrapHP columns (GE Healthcare), eluted in 
increasing concentrations of imidazole, dialysed with 20 mM sodium phosphate, 0.5 M 
NaCl (pH 7.4) and stored at -20°C. Nucleotide and amino acid sequence alignments were 
performed using ClustalW2 (Larkin et al., 2007) and sequence identity levels examined 
using MegAlign 10.0.1 (DNASTAR) based on the ClustalW2 alignments. All sequences 
were translated and molecular mass estimations made using the Sequence Manipulation 
Suite (http://www.bioinformatics.org/sms2/protein_mw.html). Cy-GALA recombinant 
proteins were prepared as described in Mitchell et al. (2016).   
 
2.4. Immunogenicity and specificity of recombinant Cy-CID proteins assessed by 
immunoblotting 
To assess the immunogenicity and cyathostomin specificity of recombinant Cy-CID 
proteins, IgG (T) reactivity to each protein was assessed by immunoblotting using sera 
pooled from three CI horses at 12-16 weeks post-infection; these time points being 
selected due to high serum IgG(T) reactivity to native larval antigen complexes (Dowdall 
et al., 2002). Reactivity in the CI pool was compared to IgG(T) in control sera prepared 
from three HF animals (Section 2.2). Cross-reactivity to other helminth species was 
investigated using serum from individuals mono-specifically infected experimentally with 
either Parascaris spp., Strongylus edentatus, Strongylus vulgaris or Strongylus westeri 
(McWilliam et al. 2010). For blotting, 0.1 g of each protein was loaded per lane onto 15-
well, 12% NuPAGE gels with SeeBlue Plus2 protein standards used for size estimations 
(Invitrogen). An additional lane was loaded with 0.1 g of each recombinant protein. After 
electrophoresis, this lane was removed and stained with Coomassie blue for comparison 
with the immunoblots. Blocking, primary, secondary and tertiary antibody steps and blot 
development were as described in McWilliam et al. (2010).   
 
2.5.  Immunoreactivity of the recombinant Cy-CID proteins and Cy-CID/Cy-GALA 
protein combinations assessed by ELISA 
Once the immunogenicity and specificity of each Cy-CID protein was confirmed by 
immunoblotting, ELISA was used to evaluate serum IgG(T) levels to each in uninfected 
and infected equids. Antigen-specific IgG(T) was measured in samples from naturally-
infected horses from an abattoir in the UK (n=26) for which the cyathostomin burden was 
known and cyathostomin-infected horses from the US (n=48, including 10 naturally-
infected horses and 38 horses administered with experimental infections, Monahan et al., 
1997; Monahan et al., 1998; Chapman et al., 2002b). Antigen-specific IgG(T) levels in 
these groups were compared with those in true cyathostomin-negative horses (US
cyathostomin-free horses infected with S. vulgaris, P. equorum or S. westeri and UK non-
infected horses raised in a helminth-free environment [n=6]). Wells of ELISA plates (96-
well flat bottomed Microlon High binding plates, Greiner Bio-One) were coated with 
recombinant CID antigens at 2 µg/ml, diluted in 100 µl coating buffer (0.1 M carbonate 
coating buffer, pH 9.6) and incubated overnight at 4°C. Plates were washed six times with 
0.05% Tween-20 in 1X PBS (PBS-T), then blocked using 200 l block buffer (2% soya 
infant formula [Wysoy, SMA nutrition], w/v in 1X PBS), per well for 1 h at 37oC. All 
serum dilutions were made in block buffer. Plates were washed six times (as above) and 
100 µl sera (diluted 1:800) added to each well and incubated for 2 h at 37oC. Each sample 
was tested in triplicate. Plates were washed six times, incubated for 1 h with (100 µl per 
well) goat anti-horse IgG(T) HRP (AbD Serotec, AAI38P), diluted 1:5,000 in block buffer. 
Reactions were developed by adding 100 µl o-Phenylenediamine dihydrochloride (OPD) 
solution prepared from SIGMAFAST OPD tablets (Sigma Aldrich) to each well. After 15 
min at room temperature, 50 µl 2.5 M H2SO4 were added to stop reactions and absorbance 
in each well read at an optical density (OD) of 490 nm. On all plates, aliquots from the 
same pool of CI and HF sera were tested in triplicate as positive and negative controls, 
respectively, for inter-plate variation. Results were expressed as the percentage OD of the 
CI sample mean for each plate. Minitab 17 Statistical Software for Windows was used for 
statistical analysis. For cyathostomin infected populations, group medians of the 
percentage positivity were compared to those of true cyathostomin-negative horses by the 
Mann-Whitney test. A p value <0.05 was taken to indicate statistical significance. 
Combinations of Cy-CID and/or Cy-GALA proteins were subsequently assessed for 
diagnostic performance based on Receiver Operator Characteristic (ROC)-curve analysis 
(see below) of ELISA data obtained using each Cy-GALA (Mitchell et al. 2016) and Cy-
CID protein. Protein combinations (cocktails, CT) were then tested as follows:  
 CT3: Cy-GALA-cat, Cy-GALA-lon, Cy-CID-nas, 
 CT5: Cy-GALA-pat, Cy-GALA-cat, Cy-GALA-ash, Cy-GALA-gol, Cy-GALA-
lon,  
 CT6: Cy-GALA-pat, Cy-GALA-cat, Cy-GALA-ash, Cy-GALA-gol, Cy-GALA-
lon, Cy-CID-nas.  
 
2.6.  Data analysis 
ROC curve analysis is frequently used in diagnostic test development to demonstrate the 
connection between sensitivity and specificity, allowing an assessment of trade-off of 
diagnostic sensitivity against specificity over a range of cut-offs to inform test design.  The 
area under the ROC curve provides a value relating to test performance. As an estimate of 
test accuracy, the area under the curve (AUC) may be interpreted such that; an AUC=0.9-
1.0 demonstrates excellent discrimination between positive and negative results; an 
AUC=0.8-0.9, good discrimination; an AUC=0.7-0.8, fair discrimination; an AUC=0.6-
0.7, poor discrimination and an AUC=0.5-0.6, no discrimination (Swets, 1988). Here, 
ROC curve analysis was undertaken to indicate the diagnostic accuracy of each protein or 
protein combination ELISA result relating to cyathostomin infection (postive or negative) 
and also to cyathostomin total mucosal burden (TMB) and total worm burden (TWB). 
Data were subjected to ROC analysis using Prism 6 (Graphpad Software Inc, USA). In 
addition to this analysis,  performed on the antigen 
combination (CT3, CT5, CT6) data. The variables examined were ELISA percentage 
positivity values versus TMB and TWB. Minitab 17 Statistical Software for Windows was 





3.1.  Analysis of Cy-CID sequences 
Following identification of antigen Cy-CID by screening a cyathostomin cDNA library 
using infected sera (McWilliam et al., 2010), a region of Cy-cid-encoding orthologous 
sequences was amplified from single adult worms of the following species, C. nassatus 
(n=2), C. pateratum (n=3), C. ashworthi (n=1), C. goldi (n=2) and C. longibursatus (n=4). 
The sequences from the two C. nassatus adults were 96-99% identical to the original 
cDNA library clone, confirming its identity as C. nassatus. Comparative sequence analysis 
(Fig. 1) of the Cy-CID orthologs revealed a high degree of inter-species sequence 
conservation over the transcript. The Cy-CID-ash sequence demonstrated 98% identity 
with the consensus Cy-CID-nas sequence. The consensus sequence from C. goldi worms 
demonstrated 95.3% amino acid identity to the Cy-CID-nas consensus sequence. The 
consensus Cy-CID-lon sequence displayed 95.1% to the Cy-CID-nas consensus sequence, 
while the Cy-CID-pat consensus sequence demonstrated 91.2% identity to the consensus 
sequence from C. nassatus. No functional domains were identified in any sequence, nor 
were significantly matching orthologous sequences found in non-cyathostomin species.  
 
3.2.  Immunoreactivity and cyathostomin specificity of the recombinant Cy-CID 
proteins and time course dynamics of IgG(T) levels in experimentally infected horses 
Subsequent to production and purification of recombinant proteins, Cy-CID-ash, Cy-
CID-gol, Cy-CID-lon, Cy-CID-pat and Cy-CID-nas, a Coomassie blue stained 12% SDS-
PAGE gel (Fig. 2A) confirmed that the approximate size observed for each antigen 
corresponded to its calculated molecular mass. Immunoblot analysis (Fig. 2B), 
demonstrated that all Cy-CID recombinant proteins were specifically bound by IgG(T) in 
sera pooled from three equids experimentally infected with cyathostomins (CI sera), 
whereas IgG(T) in sera from six HF horses lacked reactivity. In terms of cross reactivity to 
other helminth species, there was negligible IgG(T) binding to each Cy-CID protein in sera 
obtained from individual horses that were mono-specifically infected with the species, 
Parascaris spp., S. edentatus, S. vulgaris or S. westeri nematodes. 
To evaluate specific serum IgG(T) responses to each of the five recombinant Cy-CID 
proteins, an ELISA time-course study over a repeated cyathostomin larval infection series 
was performed. Antigen-specific IgG(T) levels of infected equids (101, 104, 105) were 
analysed prior to infection and until 16 weeks after initial larval challenge and compared to 
IgG(T) levels in uninfected equids (102, 103, 106). Comparable with the previously 
observed IgG(T) responses in the same horses to Cy-GALA antigens (Mitchell et al., 
2016), Fig. 3 demonstrates an increase in antigen-specific IgG(T) to Cy-CID antigens 
around 4-5 weeks after initial challenge. However, when examining serum antibody 
response dynamics between horses to the different Cy-CID proteins, this was observed to 
be more variable when compared to the observed IgG(T) responses to Cy-GALA proteins 
in the same horses (Mitchell et al., 2016). Specifically, the dynamics of the serum IgG(T) 
response to the Cy-CID-ash and Cy-CID-gol antigens varied between different infected 
animals. The pattern of IgG(T) responses to Cy-CID-lon, Cy-CID-pat and Cy-CID-nas 
were more consistent across infected individuals, reaching a plateau after an initial 
increase in IgG(T) at 4-6 weeks post challenge, before a subsequent decline in antigen 
specific antibody. Despite an initial slower serum IgG(T) response in animal 101 to Cy-
CID-nas, equivalent IgG(T) levels were measured in all infected horses by the end of the 
time-course. Antigen-specific IgG(T) levels in the uninfected controls were negligible 
across the entire experiment. 
 
3.3. ELISA and ROC curve analysis of serum IgG(T) responses to recombinant Cy-
CID proteins in cyathostomin-infected horses with enumerated worm burdens 
Serum IgG(T) levels to individual Cy-CID proteins were compared using samples from 
equids with enumerated burdens, allowing comparison of parasitological parameters with 
specific IgG(T) levels in matched end-point sera. Serum IgG(T) levels of cyathostomin-
infected horses were compared with cyathostomin-negative horses raised helminth-free. 
Antigen-specific IgG(T) was significantly higher (P<0.05) in cyathostomin-positive horses 
(n=74) than in cyathostomin-negative horses (n=9) for Cy-CID-ash (P<0.0001), Cy-CID-
nas (P=0.0001) and Cy-CID-pat (P=0.0275). Signficant differences in antigen-specific 
serum IgG(T) levels between the two groups were not observed for ELISA experiments 
performed with the Cy-CID-gol (P=0.2105) and Cy-CID-lon (P=0.0579) proteins.  
To further evaluate the potential of individual Cy-CID antigens for discriminating 
between cyathostoin-negative and -positive horses, ELISA results from equids for which 
worm burden data was available were subjected to ROC curve analysis (Table 1). For all 
proteins, antigen-specific IgG(T) levels in cyathostomin-negative equids were compared to 
those in cyathostomin-infected horses. Likelihood ratios and percentage sensitivity and 
specificity values were generated by the software package; these values were used to 
calculate cut-off percentage positivity thesholds for each protein. The cut-off values were 
selected on the basis of the highest sum of percentage sensitivity and specificity and a 
likelihood ratio generated for each protein.  High AUC values (i.e. >0.9) were obtained for 
Cy-CID-ash and Cy-CID-nas proteins. The highest level of sensitivity was demonstrated 
for Cy-CID-nas (90.41%), with 100% specificity observed for Cy-CID-gol. Next, AUC 
values at different thresholds of TMB and TWB levels were compared to assess if the 
outputs were likely to be confounded by the half-life of Cy-CID-specific serum IgG(T) 
responses; for example, in equids where there had been recent emergence of previously 
encysted larvae or in those horses that had recently been treated with an effective larvicidal 
compound. For all proteins, the AUC, sensitivity and specificity values were higher for 
TWB than TMB (Table 1). For example, for den threshold, AUC values for Cy-
CID-ash and Cy-CID-nas were 0.91 and 0.92 compared to 0.73 and 0.79 for TWB and 
TMB, respectively. Horses were also grouped on the basis of a threshold of 5,000 TMB or 
TWB. At a cut-off of a TMB of 5,000 larvae, AUC values of individual Cy-CID proteins 
ranged from 0.58 (Cy-CID-gol) to 0.75 (Cy-CID-nas). When taking luminal burden into 
account at a cut-off of 5,000 TWB, Cy-CID-nas (AUC value = 0.78) gave the highest 
value. When cyathostomin worm burden data were partitioned at a level of 10,000 TMB 
/TWB or above, AUC values generated by the ROC curve analysis were <0.7 (data not 
shown), indicating poor discrimination between the positive and negative groupings at 
these higher burden thresholds. 
 
3.4.  ELISA and ROC curve analysis of serum IgG(T) responses to combinations of 
recombinant Cy-CID and Cy-GALA proteins in cyathostomin-infected horses 
To take account of the fact that cyathostomin infections are multi-species, the next step 
was to test combinations of antigens from common species. Analysis of Cy-CID and Cy-
GALA antigen combinations were assessed as antibody responses to single recombinant 
helminth antigens have been shown to be genetically restricted such that some individuals 
are non-resposive despite being infected (Trenholme et al., 1994). ROC curve AUC values 
obtained previously for Cy-GALA proteins were generally higher (Mitchell et al., 2016) 
than those observed for Cy-CID proteins; for example, when studying horse serum IgG(T) 
responses grouped as infected versus non-infected, Cy-GALA antigen ROC AUC values 
range from 0.91-0.93 (Mitchell et al., 2016), compared to a range of ROC AUC values of 
0.65-0.92 for Cy-CID antigens (with the highest value measured for Cy-CID-nas). 
Likewise, when assessing a 5,000 TWB threshold, Cy-GALA proteins give a range of 
ROC AUC values from 0.75 (Cy-GALA-ash) to 0.82 (Cy-GALA-lon, Cy-GALA-cat). 
Similar results were obtained for a TMB threshold of 5,000 worms. In these cases, ROC 
AUC values were higher for all Cy-GALA proteins, with the exception of Cy-CID-nas. 
First, all five Cy-GALA proteins were tested in a single combination, CT5, representing 
the species C. catinatum, C. pateratum, C. ashworthi, C. goldi and C. longibursatus. These 
five Cy-GALA proteins were then tested in combination with Cy-CID-nas. This protein 
gave the highest ROC curve AUC value of the CID proteins tested and represents one of 
the commonest reported species. This combination was designated CT6. Finally, a 
combination of three proteins was assessed. These proteins were selected on the basis of 
previous species prevalence reports for cyathostomins (for example, Bucknell, et al., 1995; 
Chapman et al., 2002a; 2002b; Collobert-Laugier, et al., 2002), which indicate that the 
commonest species observed across regions are C. nassatus (Cy-CID-nas), C. 
longibursatus (Cy-GALA-lon) and C. catinatum (Cy-GALA-cat). This combination was 
designated CT3.  
Levels of serum IgG(T) to the three cocktails were compared by ELISA using serum 
samples as per the single-protein analysis above. Specific serum IgG(T) levels were 
significantly higher (p<0.05) in the cyathosotmin-infected than in the -uninfected 
population for CT3, CT5 and CT6. ROC curve AUC values were calculated for the three 
cocktails at different burdens of total worms (TWB) or total mucosal worms (TMB, Table 
2). As with the individual antigens, the chosen cut-off values for each cocktail were based 
on the highest sum of percentage sensitivity and specificity and a likelihood ratio present. 
At the 0 TWB threshold, specificity was 90% for all three cocktails. A sensitivity of 
87.67%, 86.30% and 91.78% was reported for CT3, CT5 and CT6, respectively. In terms 
of ROC curve outputs, at the 0 TWB threshold, CT3 and CT6 performed best, both 
achieving an AUC value of 0.94. For a 5,000 TWB threshold, AUC values were 0.84 for 
CT3 and CT6, and 0.80 for CT5. Thus, the use of antigen cocktails improved the AUC 
values at each of the selected worm burden thresholds, with the highest values obtained 
when the Cy-GALA antigens were combined with a Cy-CID antigen from C. nassatus. 
When cyathostomin burden data were partitioned at a level of 10,000 TMB or TWB or 
above, most AUC values generated by ROC curve analysis were <0.7 (data not shown), 
indicating poor discrimination between the positive and negative groupings on the basis of 
these higher worm burden thresholds.  
Spearman performed using the ELISA data for each protein 
combination for all cyathostomin infected horses (Table 3). Significant positive 
correlations between the ELISA data and the cyathostomin worm burden parameters were 
observed for CT3 and CT6, which included the CID proteins, but not for the CT5, which 
comprised only GALA proteins. 
 
4. Discussion 
The lack of a diagnostic test for cyathostomin intra-host stages, including encysted 
larvae, means that in some regions, whole-group administration of an annual anthelmintic 
treatment is commonly recommended in autumn/winter (Tzelos and Matthews, 2016; 
Rendle et al., 2019). With no new equine anthelmintic compounds on the horizon, a 
reduction in unnecessary treatments is paramount to preserve efficacy, in particular, of 
moxidectin, currently the only compound widely effective against encysted cyathostomin 
larvae. The availability of a test that provides information on the presence, or burden, of 
cyathostomin infections could benefit specific targeting of equine anthelmintics to lower 
treatment frequency and hence reduce selection pressure for anthelmintic resistance 
(Matthews, 2014). The current study describes key steps that identified two cyathostomin 
proteins, Cy-GALA and Cy-CID, that could be used in such a test to inform on the 
presence or level of infection of cyathostomins in horses.   
Due to the complexity of cyathostomin infections, development of a test for these 
nematodes is challenging (Lichtenfels et al., 2008). The studies here sought to define 
serum IgG(T) responses in infected horses to two antigens from the most commonly 
reported species.  Cy-CID antigen was identified by immuno-screening a mixed mucosal 
stage cDNA library. The Cy-cid transcript was detected by reverse transcriptase PCR in 
late mucosal larval stages and in luminal stage parasites (unpublished data). The 
developmental expression profile of Cy-cid is therefore complementary to that of Cy-gala, 
shown previously to be expressed in early and late mucosal larval stages, but undetectable 
by reverse transcriptase PCR in luminal stage worms (McWilliam et al., 2010). When Cy-
CID sequences were compared among cyathostomin species, it was observed that, similar 
to Cy-GALA, the Cy-CID sequences demonstrated a high degree of conservation and high 
intra-specific identity. Since heterologous species seemingly lack orthologous Cy-CID 
sequences, these proteins may be cyathostomin-specific. The genomes and transcriptomes 
of rarer nematode species are yet to be analysed; ongoing sequencing projects could reveal 
the presence of Cy-CID orthologs outside the Cyathostominae group. 
Here, Cy-CID proteins representing five common species were expressed as 
recombinant proteins and cyathostomin specificity of each confirmed by an absence of 
immune-reactivity of each protein to IgG(T) in sera from horses harbouring non-
cyathostomin helminths. Immuno-blotting studies also demonstrated that each Cy-CID 
protein was strongly reactive with serum IgG(T) from cyathostomin-infected horses. For 
the Cy-CID-ash, Cy-CID-pat and Cy-CID-nas proteins, these results were further 
supported by ELISA data that demonstrated significantly higher antigen-specific serum 
IgG(T) levels to each protein in cyathostomin-infected equids compared to equids that had 
no prior exposure to cyathostomin infection. The time-course study provided additional 
support for the diagnostic potential of the CID antigens, demonstrating consistent specific 
serum IgG(T) responses, in particular to the Cy-CID-pat and Cy-CID-nas proteins, in all 
infected horses, with lowest background reactivity observed to the Cy-CID-nas protein. 
The CID proteins were thereafter assessed for their ability to define the presence of 
infection, or infection level, at increasing cyathostomin burden thresholds in a larger 
cohort of horses. The ROC curve analysis demonstrated high AUC values generated from 
the ELISA analysis using the C. nassatus and C. ashworthi CID proteins, but lower AUC 
values when analysing IgG(T) responses to CID proteins representing C. goldi, C. 
longibursatus and C. pateratum. In previous studies using sera from the same cohort of 
horses, all cyathostomin GALA proteins consistently achieved AUC values in excess of 
0.9 (Mitchell et al., 2016). Here, only Cy-CID-nas and Cy-CID-ash ELISA data generated 
similar AUC scores, in agreement with the significantly higher specific IgG(T) response to 
Cy-CID-nas and Cy-CID-ash in comparison to the other Cy-CID proteins. Cylicocyclus 
nassatus is reported as one of the most prevalent and abundant species infecting 
domesticated equids (Krecek et al., 1989, Bucknell et al., 1995; Kuzmina et al., 2005, 
Traversa et al., 2009). Cylicocyclus ashworthi is also common, despite previous reports 
underestimating its prevalence due to misidentification because of high morphological 
similarity to C. nassatus (Chapman et al., 2002a). An explanation for the observed 
differences in IgG(T) response to the various Cy-CID antigens could be that some 
recombinant proteins might be more inherently immunogenic than others. 
Variation in individual s immune responses is a feature of helminth infections and, to 
account for potential heterogeneity in the host antibody repertoire, antibody responses to 
combinations of proteins are generally deemed to be more informative in defining worm 
infection status (Bradley et al., 1991; Li et al., 2011). Hence, the next step in this study was 
to examine three combinations of the best-performing antigens from the individual-protein 
analysis, also taking into account previous literature on individual species abundance. 
Antigens were thus selected from the three commonest species reported, C. longibursatus, 
C. nassatus and C. catinatum, and from two further common species, C. ashworthi and C. 
pateratum (Krecek et al., 1989; Mfitilodze and Hutchinson, 1990; Bucknell et al., 1995; 
Gawor, 1995; Lichtenfels et al., 2001; Kuzmina et al., 2005) Both ROC curve and 
statistical correlation analysis of the performance of the three antigen combinations 
indicated that CT3 and CT6 gave the best discriminatory information when comparing 
cyathostomin-negative to cyathostomin-positive individuals. For both antigen 
combinations, derived AUC values were >0.9, representing excellent accuracy for a 
diagnostic test (Swets, 1988). Stratification of the horses based on TWB, rather than on 
mucosal worm burden, resulted in higher AUC scores. A potential explanation for this 
observation could be the presence of residual specific IgG(T) to recently emerged larvae. 
In terms of worm burden thresholds, the test performed well up to a burden of 5,000 
cyathostomins. One reason for this is that, as evidenced by the experimental-infection 
time-course study where IgG(T) levels to both Cy-CID and Cy-GALA antigens were 
measured, IgG(T) levels displayed a plateau pattern 8-10 weeks after initial infection, 
despite continuous larval challenge. Inclusion of three additional Cy-GALA antigens in 
CT6 did not appear to substantially increase the overall accuracy of the test compared to 
the CT3 combination. Therefore, to balance the financial resource required for antigen 
generation with the diagnostic value provided by the protein combination, CT3 was 
selected for downstream development in a commercial setting.  
Determination of a reliable cut-off value for diagnosis of this disease is not a trivial task 
and factors other than test performance need to be considered, i.e. the overall benefit to the 
animal as well as the entire co-grazing population. Clinical larval cyathostominosis is a 
serious condition but is relatively uncommon; however, to minimise potential 
misdiagnosis, a suitable worm burden theshold needs to be selected to avoid such a 
scenario occurring. The threshold of burden selected must also take into account owner 
perception as to what level represents a substantial  worm burden; otherwise they may 
not engage in using a test if they consider the parasite threshold selected for treatment as
too high. Unfortunately, there is no data published that indicates the level of cyathostomin 
burden that can lead to disease. Further, the cost of incorrectly classifying an infected 
animal as non-infected would be conceived by most owners to outweigh the cost (i.e. 
anthelmintic treatment) of a potential false-positive diagnosis. Potential residual IgG(T) 
from past infection can have confounding effects on assay accuracy. Since the serum half-
life of equine IgG(T) has been reported as 21 days (Sheoran et al., 2000), this also needs to 
be taken into account in applying the test in practice. Thus, the test result must be 
interpreted alongside the clinical and treatment history of the individual/population under 
assessment. Monitoring of antigen-specific serum IgG(T) responses in individuals after 
moxidectin administration will provide further insight into temporal dynamics of antibody 
responses post-treatment and will inform application of this test in practice. Equine 
parasitology experts advocate application of moxidectin in moderate-high risk animals at 
the end of the grazing season to reduce the risk of larval cyathostominosis (Rendle et al., 
2019). Thus, the timing of use of this test is likely to provide most value if used in northern 
temperate regions in autumn/early winter, when it can be employed to inform on the need 
for a larvicidal treatment.  
This serum-based test has subsequently been validated in a commerical setting (Austin 
Davis Biologics Ltd., UK) and optimised for use in a robotic system. Where matching 
serum samples could be assessed, outputs were compared with the prototype test described 
here; significant correlations were demonstrated between the two methods (Matthews, 
Austin, et al., unpublished data). The commercial version of the test was launched in the 
UK in September 2019 (www.austindavis.co.uk/small-redworm-blood-test).  In selecting 
thresholds for treatment, the requirement for high sensitivity to minimise false negatives 
was made. The veterinarian s decision to use the test and apply its outputs to inform the 
application of anthelmintic treatment are defined in guidelines developed to be used in 
interpreting the outputs of the ELISA and are based on the CT3-specific antibody level
measured, expressed as a serum score , taking into account the grazing management and 
historic parasitological (FEC) parameters of the individual or group being tested.   
 
Acknowledgements 
The authors would like to that all veterinary surgeons who supplied the sera used in this 
study and Professor Tom Klei (Louisiana State University, USA) and Professor Sandy 
Love (University of Glasgow) for the supply of sera from the experimental studies.  
Financial support 
The authors would like to thank the Horse Trust, the Horserace Betting Levy Board and 
the Thoroughbred Breeders Association for their generous financial support of this project.  
 
Declarations of interest: none  
  
References
Bradley, J.E., Helm, R., Lahaise, M., Maizels, R.M., 1991. cDNA clones of Onchocerca 
volvulus low molecular weight antigens provide immunologically specific diagnostic 
probes. Molecular and Biochemical Parasitology 46, 219-227. 
Bucknell, D.G., Gasser, R.B., Beveridge, I., 1995. The prevalence and epidemiology of 
gastrointestinal parasites of horses in Victoria, Australia. International Journal for 
Parasitology 25, 711-724. 
Canever, R.J., Braga, P.R., Boeckh, A., Grycajuck, M., Bier, D., Molento, M.B., 2013. 
Lack of cyathostomin sp. reduction after anthelmintic treatment in horses in Brazil. 
Veterinary Parasitology 194, 35-39. 
Chapman, M.R., French, D.D., Klei, T.R., 2002a. Gastrointestinal helminths of ponies in 
Louisiana: a comparison of species currently prevalent with those present 20 years ago. 
The Journal of Parasitology 88, 1130-1134. 
Chapman, M.R., French D.D., Taylor H.W., Klei, T.R., 2002b.  One season of pasture 
exposure fails to induce a protective resistance to cyathostomins but increases numbers of 
hypobiotic third stage larvae. Journal of Parasitology 88, 678-683. 
Collobert-Laugier, C., Hoste, H., Sevin, C., Dorchies, P., 2002. Prevalence, abundance and 
site distribution of equine small strongyles in Normandy, France. Veterinary Parasitology 
110, 77-83. 
Dowdall, S.M., Matthews, J.B., Mair, T., Murphy, D., Love, S., Proudman, C.J., 2002. 
Antigen-specific IgG(T) responses in natural and experimental cyathostominae infection in 
horses. Veterinary Parasitology 106, 225-242. 
Dowdall, S.M., Proudman, C.J., Love, S., Klei, T.R., Matthews, J.B., 2003. Purification 
and analyses of the specificity of two putative diagnostic antigens for larval cyathostomin 
infection in horses. Research in Veterinary Science 75, 223-229. 
Dowdall, S.M., Proudman, C.J., Klei, T.R., Mair, T., Matthews, J.B., 2004. 
Characterisation of IgG(T) serum antibody responses to two larval antigen complexes in 
horses naturally- or experimentally-infected with cyathostomins. International Journal for 
Parasitology 34, 101-108. 
Easton, S., Pinchbeck, G.L., Tzelos, T., Bartley, D.J., Hotchkiss, E., Hodgkinson, J.E., 
Matthews, J.B., 2016. Investigating interactions between UK horse owners and prescribers 
of anthelmintics. Prev. Vet. Med. 135, 17-27. 
Edgar, R.C. 2004 MUSCLE: multiple sequence alignment with high accuracy and high 
throughput. Nucleic Acids Research 32, 1792-1797. 
Else, K., Wakelin, D. 1989., Genetic variation in the humoral immune responses of mice to 
the nematode Trichuris muris. Parasite Immunology 11, 77-90. 
Gawor, J.J., 1995. The prevalence and abundance of internal parasites in working horses 
autopsied in Poland. Veterinary Parasitology 58, 99-108. 
Geurden, T., van Doorn, D., Claerebout, E., Kooyman, F., De Keersmaecker, S., 
Vercruysse, J., Besognet, B., Vanimisetti, B., di Regalbono, A.F., Beraldo, P., Di Cesare, 
A., Traversa, D., 2014. Decreased strongyle egg re-appearance period after treatment with 
ivermectin and moxidectin in horses in Belgium, Italy and The Netherlands. Veterinary 
Parasitology. 204, 291-296. 
Giles, C.J., Urquhart, K.A., Longstaffe, J.A., 1985. Larval cyathostomiasis (immature 
trichonema-induced enteropathy): a report of 15 clinical cases. Equine Veterinary Journal 
17, 196-201. 
Kaplan, R.M., 2002. Anthelmintic resistance in nematodes of horses. Veterinary Research 
33, 491-507. 
Kaplan, R.M., Nielsen, M.K., 2010. An evidence-based approach to equine parasite 
control: It ain't the 60s anymore. Equine Vet. Educ. 22, 306-316. 
Klei, T.R., Torbert, B.J., Chapman, M.R., Ochoa, R., 1982. Irradiated larval vaccination of 
ponies against Strongylus vulgaris. The Journal of Parasitology 68, 561-569. 
Krecek, R.C., Reinecke, R.K., Horak, I.G., 1989. Internal parasites of horses on mixed 
grassveld and bushveld in Transvaal, Republic of South Africa. Veterinary Parasitology 
34, 135-143. 
Kuzmina, T.A., Kharchenko, V.A., Starovir, A.I., Dvojnos, G.M., 2005. Analysis of the 
strongylid nematodes (Nematoda: Strongylidae) community after deworming of brood 
horses in Ukraine. Veterinary Parasitology 131, 283-290. 
Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., McWilliam, 
H., Valentin. F, Wallace, I.M., Wilm, A., Lopez, R., Thompson, J.D., Gibson, T.J., 
Higgins, D.G., 2007. Clustal W and Clustal X version 2.0.  Bioinformatics 23, 2947-2948. 
Lester, H.E., Spanton, J., Stratford, C.H., Bartley, D.J., Morgan, E.R., Hodgkinson, J.E., 
Coumbe, K., Mair, T., Swan, B., Lemon, G., Cookson, R., Matthews, J.B., 2013. 
Anthelmintic efficacy against cyathostomins in horses in Southern England. Veterinary 
Parasitology 197, 189-196. 
Li, S., Shin, J.G., Cho, P.Y., Kim, T.Y., Hong, S.T., Hong, S.J., 2011. Multiple 
recombinant antigens of Clonorchis sinensis for the serodiagnosis of human clonorchiasis. 
Parasitology Research 108, 1295-1302. 
Lichtenfels, J.R., McDonnell A., Love, S., Matthews, J.B., 2001. Nematodes of the tribe 
Cyathostominea (Strongylidae) collected from horses in Scotland. Comparative 
Parasitology 68, 265 268. 
Lichtenfels, J.R., Kharchenko, V.A., Dvojnos, G.M., 2008. Illustrated identification keys 
to strongylid parasites (Strongylidae: Nematoda) of horses, zebras and asses (Equidae). 
Veterinary Parasitology 156, 4-161. 
Love, S., Mair, T.S., Hillyer, M.H., 1992. Chronic diarrhoea in adult horses: a review of 51 
referred cases. The Veterinary Record 130, 217-219. 
Lyons, E.T., Tolliver, S.C., Drudge, J.H., 1999. Historical perspective of cyathostomes: 
prevalence, treatment and control programs. Veterinary Parasitology 85, 97-111; 
discussion 111-112, 215-125. 
Matthews, J.B., 2008. An update on cyathostomins: Anthelmintic resistance and worm 
control. Equine Veterinary Education 20, 552-560. 
Matthews, J.B., 2014. Anthelmintic resistance in equine nematodes. Int. J. Parasitol.: 
Drugs Drug Resist. 4, 310-315. 
McKeand, J.B., Knox, D.P., Duncan, J.L., Kennedy, M.W., 1994. Genetic control of the 
antibody repertoire against excretory/secretory products and acetylcholinesterases of 
Dictyocaulus viviparus. Parasite Immunology 16, 251-60. 
McWilliam, H.E., Nisbet, A.J., Dowdall, S.M., Hodgkinson, J.E., Matthews, J.B., 2010. 
Identification and characterisation of an immunodiagnostic marker for cyathostomin 
developing stage larvae. International Journal for Parasitology 40, 265-275. 
Mfitilodze, M.W., Hutchinson, G.W., 1990. Prevalence and abundance of equine 
strongyles (Nematoda: Strongyloidea) in tropical Australia. The Journal of Parasitology 
76, 487-494. 
Mitchell, M.C., Tzelos, T., Handel, I., McWilliam, H.E., Hodgkinson, J.E., Nisbet, A.J., 
Kharchenko, V.O., Burgess, S.T., Matthews, J.B., 2016. Development of a recombinant 
protein-based ELISA for diagnosis of larval cyathostomin infection. Parasitology 143, 
1055-1066. 
Monahan, C.M., Chapman, M.R., Taylor, H.W., French, D.D., Klei, T.R., 1996. 
Comparison of moxidectin oral gel and ivermectin oral paste against a spectrum of internal 
parasites of ponies with special attention to encysted cyathostome larvae. Veterinary 
Parasitology 63, 225-235. 
Monahan, C.M., Chapman, M.R., Taylor, H.W., French, D.D., Klei, T.R., 1997. Foals 
raised on pasture with or without daily pyrantel tartrate feed additive: comparison of 
parasite burdens and host responses following experimental challenge with large and small 
strongyle larvae. Veterinary Parasitology 73, 277-289. 
Monahan, C.M., Chapman, M.R., Taylor, H.W., French, D.D., Klei, T.R, 1998. 
Experimental cyathostome challenge of ponies maintained with or without benefit of daily 
pyrantel tartrate feed additive: comparison of parasite burdens, immunity and colonic 
pathology. Veterinary Parasitology 74, 229-241. 
Murphy, D., Love, S., 1997. The pathogenic effects of experimental cyathostome 
infections in ponies. Veterinary Parasitology 70, 99-110. 
Nielsen, M.K., Pfister, K., von Samson-Himmelstjerna, G., 2014. Selective therapy in 
equine parasite control-application and limitations. Veterinary Parasitology 202, 95-103. 
Ogbourne, C.P., 1976. The prevalence, relative abundance and site distribution of 
nematodes of the subfamily Cyathostominae in horses killed in Britain. Journal of 
Helminthology 50, 203-214. 
Reinemeyer, C.R., Smith, S.A., Gabel, A.A., Herd, R.P., 1984. The prevalence and 
intensity of internal parasites of horses in the U.S.A. Veterinary Parasitology 15, 75-83. 
Relf, V.E., Morgan, E.R., Hodgkinson, J.E., Matthews, J.B., 2013. Helminth egg excretion 
with regard to age, gender and management practices on UK Thoroughbred studs. 
Parasitology 140, 641-652. 
Relf, V.E., Lester, H.E., Morgan, E.R., Hodgkinson, J.E., Matthews, J.B., 2014. 
Anthelmintic efficacy on UK Thoroughbred stud farms. International Journal for 
Parasitology 44, 507-514. 
Rendle, D., Austin, C., Bowen, M., Cameron, I., Furtado, T., Hodgkinson, J., McGorum, 
B., Matthews, J., 2019. Equine De-worming: a consensus on current best practice. UK-
Vet-Equine 3, S1. 
Rossano, M.G., Smith, A.R., Lyons, E.T., 2010. Shortened strongyle-type egg 
reappearance periods in naturally infected horses treated with moxidectin and failure of a 
larvicidal dose of fenbendazole to reduce fecal egg counts. Veterinary Parasitology 173, 
349-352. 
Sangster, N., 2003. A practical approach to anthelmintic resistance. Equine Veterinary 
Journal 35, 218-219. 
Sheoran, A.S., Timoney, J.F., Holmes, M.A., Karzenski, S.S., Crisman, M.V., 2000.  
Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer 
and distribution in horses.  American Journal of Veterinary Research 61, 1099-1105. 
Swets, J.A. 1988. Measuring the accuracy of diagnostic systems. Science 240, 1285-1293.
Traversa, D., von Samson-Himmelstjerna, Demeler, J., Milillo, P., Schurmann, S., Barnes, 
H., Otranto, O., Perrucci, S., di Regalbono, A.F., Beraldo, P.,  Boeckh, A., Cobb, R. 2009. 
Anthelmintic resistance in cyathostomin populations from horse yards in Italy, United 
Kingdom and Germany. Parasites and Vectors 2, S2. 
Trenholme, K.R., Tree, T.I., Gillespie, A.J., Guderian, R., Maizels, R.M., Bradley, J.E. 
1994. Heterogeneity of IgG antibody responses to cloned Onchocerca volvulus antigens in 
microfiladermia positive individuals from Esmeraldas Province, Ecuador. Parasite 
Immunology 16, 201-209. 
Tzelos, T., Matthews, J., 2016. Anthelmintic resistance in equine helminths and mitigating 
its effects. In Practice 38, 489-499. 
Tzelos, T., Barbeito, J.S., Nielsen, M.K., Morgan, E.R., Hodgkinson, J.E., Matthews, J.B., 
2017. Strongyle egg reappearance period after moxidectin treatment and its relationship 
with management factors in UK equine populations. Veterinary Parasitology. 237, 70-76. 
Tzelos, T., Morgan, E.R., Easton, S., Hodgkinson, J.E., Matthews, J.B., 2019. A survey of 
the level of horse owner uptake of evidence-based anthelmintic treatment protocols for 
equine helminth control in the UK. Veterinary Parasitology. 274, 108926. 
Wood, E.L., Matthews, J.B., Stephenson, S., Slote, M., Nussey, D.H., 2013. Variation in 
fecal egg counts in horses managed for conservation purposes: individual egg shedding 
consistency, age effects and seasonal variation. Parasitology 140, 115-128. 
Table 1. Receiver operator characteristic (ROC) curve analysis of ELISA data relating to 
antigen-specific IgG(T) levels comparing cyathostomin-positive (Pos; n=73) to negative 
(Neg; n=10) horses. Horses stratified at 0 or 5,000 worm threshold of cyathostomins in the 
mucosa plus lumen (total worm burden, TWB) or larvae in the mucosa (total mucosal 
burden, TMB). Area under the curve (AUC), 95% confidence intervals (CI) and P values 
for data generated by ROC curve analysis for each protein are shown. The cut-off value 
indicated is based on the value calculated as the highest sum of percentage sensitivity and 










Neg: 10  
Pos: 73 
Cy-CID-pat 0.74 (0.61-0.87) 0.015 >28.44 60.27 (48.14-71.55) 90.00 (55.50-99.75) 
Cy-CID-ash 0.91 (0.84-0.98) < 0.001 >26.51 84.93 (74.64-92.23) 90.00 (55.50-99.75) 
Cy-CID-gol 0.65 (0.49-0.82) 0.114 >42.80 32.88 (22.33-44.87) 100 (69.15-100.0) 
Cy-CID-lon 0.67 (0.53-0.81) 0.082 >36.09 46.58 (34.80-58.63) 90.00 (55.50-99.75) 




Cy-CID-ash 0.73 (0.59-0.87) 0.003 >35.20 74.24 (61.99-84.22) 70.59 (44.04-89.69) 
Cy-CID-gol 0.60 (0.46-0.74) 0.210 >52.58 30.30 (19.59-42.85) 100 (80.49-100.0) 
Cy-CID-lon 0.70 (0.58-0.82) 0.011 >33.40 56.06 (43.30-68.26) 82.35 (56.57-96.20) 
Cy-CID-pat 0.74 (0.62-0.86) 0.003 >28.44 65.15 (52.42-76.47) 88.24 (63.56-98.54) 




Cy-CID-pat 0.73 (0.60-0.85) 0.004 >28.44 64.62 (51.77-76.08) 83.33 (58.58-96.42) 
Cy-CID-ash 0.72 (0.58-0.86) 0.005 >35.20 73.85 (61.46-83.97) 66.67 (40.99-86.66) 
Cy-CID-gol 0.63 (0.50-0.76) 0.102 >52.58 30.77 (19.91-43.45) 100.0 (81.47-100.0) 
Cy-CID-lon 0.73 (0.62-0.84) 0.003 >36.97 49.23 (36.60-61.93) 94.44 (72.71-99.86) 




Cy-CID-pat 0.64 (0.52-0.77) 0.030 >30.55 60.38 (46.00-73.55) 73.33 (54.11-87.72) 
Cy-CID-ash 0.65 (0.53-0.78) 0.021 >44.10 67.92 (53.68-80.08) 63.33 (43.86-80.07) 
Cy-CID-gol 0.58 (0.46-0.71) 0.214 >43.46 35.85 (23.14-50.20) 86.67 (69.28-96.24) 
Cy-CID-lon 0.63 (0.50-0.75) 0.054 >36.97 49.06 (35.06-63.16) 76.67 (57.72-90.07) 
Cy-CID-nas 0.75 (0.64-0.85) <0.001 >18.89 54.72 (40.45-68.44) 83.33 (65.28-94.36) 
Table 2. Receiver operator characteristic (ROC) curve analysis of ELISA data relating to 
antigen-specific IgG(T) levels comparing cyathostomin-positive (Pos; n=73) vs. 
cyathostomin-negative individuals (Neg; n=10). Horses stratified on at 0 or 5,000 worm 
threshold of cyathostomins in the mucosa plus lumen (total worm burden, TWB) or larvae 
in the mucosa (total mucosal burden, TMB). Area under the curve (AUC), 95% confidence 
intervals (CI) and P values for data generated by ROC curve analysis are shown. Cut-off 
based on the value calculated as the highest sum of percentage sensitivity and specificity 
values with a likelihood ratio present obtained in the ROC analysis. Cocktails comprised 
the following: CT3  Cy-GALA-lon, Cy-GALA-cat and Cy-CID-nas; CT5  Cy-GALA-
pat, Cy-GALA-cat, Cy-GALA-ash, Cy-GALA-gol and Cy-GALA-lon; CT6  Cy-GALA-
pat, Cy-GALA-cat, Cy-GALA-ash, Cy-GALA-gol, Cy-GALA-lon and Cy-CID-nas. 












































































































Table 3. of cyathostomin infected individuals (n=83)
comparing % positivity values for each of three protein combinations (CT3, CT5, CT6) 
with cyathostomin burden (total worm burden (TWB) and total mucosal burden (TMB). 
-
values are shown. 
Cocktail  
(% positivity values) 
Cyathostomin burden measure Spearman rho P-Value 
CT3 TWB 0.337 0.002 
CT5 TWB 0.27 0.013 
CT6 TWB 0.348 0.001 
CT3 TMB 0.267 0.015 
CT5 TMB 0.206 0.061 
CT6 TMB 0.27 0.013 
Supplementary Tables 
 
Supplementary Table 1. Details of serum samples used to test IgG(T) responses to the 
recombinant antigens including, sample numbers (n) and the original article (Reference). 
The populations were from the UK or US as described in Materials and Methods.  
 
Serum population n Reference 
UK cyathostomin infected (weeks 12 
and 16 post infection) 
3 Murphy and Love, 1997 
UK helminth free  3 Murphy and Love, 1997  
UK abattoir 26 Dowdall et al. 2004 
US naturally infected 10 Monahan et al. 1996 
US experimentally infected 38 Chapman et al. 2002b; Monahan et al. 
1997, Monahan et al. 1998 
US cyathostomin-free 3 Dowdall et al. 2003; Klei et al. 1982 
 
Supplementary Table 2. Primers used for recombinant protein expression (restriction 
SacI and NotI are highlighted in bold in forward and reverse primers, 
respectively).  






















Legend to Figures 
 
Fig. 1. Cy-CID orthologs share extensive sequence similarity. ClustalW alignment of 
Cy-CID orthologs isolated from C. pateratum (Cy-CID-pat; GenBank Accession number: 
KC759131), C. ashworthi (Cy-CID-ash; GenBank Accession number: KC759138), C. 
nassatus (Cy-CID-nas; GenBank Accession number: KC759139), C. longibursatus (Cy-
CID-lon; GenBank Accession number: KC759133), C. goldi (Cy-CID-gol; GenBank 
Accession number: KC759134). Identical residues are shaded in black and similar amino 
acids are denoted by a grey background. Multiple sequence alignment was constructed 
using MUSCLE EBI (Edgar, 2004) and Boxshade V3.2 used for alignment annotation. 
 
Fig. 2. Specificity of the five recombinant Cy-CID proteins.  A) Coomassie stained 
SDS-PAGE gel depicting molecular marker (kDa) on the left and recombinant versions of 
Cy-CID-ash, Cy-CID-gol, Cy-CID-lon, Cy-CID-pat and Cy-CID-nas in lanes 1-5 
respectively. B - F) Immunoblots of each recombinant protein (Cy-CID-ash, -gol, -lon, -
nas and -pat) probed for IgG(T) reactivity using sera from helminth free (HF) horses, 
experimental cyathostomin-infected (CI) horses and horses infected experimentally with 
Parascaris spp. (Ps), Strongylus edentatus (Se), Strongyloides westeri (Sw) or Strongylus 
vulgaris (Sv). M (kDa) = molecular weight marker.  
 
Fig. 3. Time course of IgG(T) responses in experimentally infected horses to the five 
Cy-CID antigens over time. Protein-specific IgG(T) responses (Cy-CID-ash, Cy-CID-
gol, Cy-CID-lon, Cy-CID-pat and Cy-CID-nas) were measured over an experimental 
trickle infection (Murphy and Love, 1997). Six British native-breed equids (6-12 months at 
initial infection) were reared as helminth-naïve prior to the start of the trial. Three foals 
(Ponies 101, 104 and 105; represented by markers ,  & ) were infected with a total of 
3.9 million cyathostomin third stage larvae (L3), administered as a trickle infection of 
150,000 L3 by nasogastric tube, three times a week. Foals 102, 103 and 106 (represented 
by ) were maintained as uninfected controls. Results are expressed as the 
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